Last reviewed · How we verify

NCT05293587: PARCS Pilot

Physical Activity to Reduce Diabetes Risk in Serious Mental Illness

Completed NA Last updated 1 February 2023
What this trial tests

NA trial testing Physical Activity in Mental Disorders, Severe in 20 participants. Completed in 31 August 2022.

Timeline
13 September 2021
Primary endpoint
26 August 2022
31 August 2022

Quick facts

Lead sponsorAugusta University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment20
Start date13 September 2021
Primary completion26 August 2022
Estimated completion31 August 2022
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Augusta University

Who can join

18 and older, any sex, with Mental Disorders, Severe. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this project is to trial the protocol of a park-based physical activity (PA) intervention in adults with severe mental illness (SMI) in a community mental health center's peer support program.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The PARCS Pilot Study Randomized Controlled Trial: Feasibility and Acceptability of a Park-Based Exercise Program Led by Peer Specialists for Peers with Serious Mental Illness.
    Davis CL, Bell H, Andrews V, Stewart J, et al · · 2025 · PMID 40909368

Verify or expand the search:

Other trials of Physical Activity

Trials testing the same drug.

Other recruiting trials for Mental Disorders, Severe

Currently open trials in the same condition.

Other Augusta University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05293587.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing